Condiciones de salud que cálamo puede ayudar a apoyar.
Folic acid (folate/vitamin B9) deficiency is a leading cause of megaloblastic macrocytic anemia. Folate is essential for DNA synthesis in erythroid precursors; deficiency produces abnormally large, poorly developed red blood cells. Supplementation corrects folate-deficiency megaloblastic anemia within weeks.
Folate (the natural form of vitamin B9) reduces homocysteine levels, protecting the arterial endothelium from hyperhomocysteinemia-induced damage. A 2022 network meta-analysis included folate among vitamins assessed for arterial stiffness reduction. Clinical trials show folate supplementation improves FMD and reduces arterial oxidative stress.
Folate deficiency is associated with increased hypertension risk, with a large prospective cohort (n>219,000) finding a 42% higher risk of hypertension in folate-deficient individuals. Folate's blood pressure effects are mediated partly through homocysteine lowering and through MTHFR-dependent nitric oxide production. Folic acid supplementation has shown blood pressure-lowering effects in patients with H-type hypertension (hypertension combined with hyperhomocysteinemia).
Folate is essential for one-carbon metabolism, homocysteine clearance, and synthesis of SAMe—all critical for brain neurotransmitter production and myelin integrity. Deficiency causes elevated homocysteine, neuroinflammation, and cognitive impairment including brain fog. The VITACOG trial found high-dose folate (with B12 and B6) slowed brain atrophy by ~30% in MCI patients with elevated homocysteine. Low folate is directly associated with memory and concentration difficulties.
Folate passes into breast milk, and exclusively breastfed infants depend entirely on maternal milk as their folate source. Adequate maternal folate status is essential to meet infant needs and maintain maternal erythrocyte folate. Current recommendations set intake at 500 mcg/day during lactation. Supplementation during lactation has been shown to lower maternal homocysteine and support folate stores.
Folate (vitamin B9) deficiency is associated with recurrent aphthous stomatitis (RAS). A controlled dietary study (PMC3323114; n=100 RAS patients) found significantly reduced dietary folate intake in RAS patients versus matched controls. StatPearls (NCBI Bookshelf) and EBSCO Research Starters confirm folate as one of the hematinic supplements prescribed for RAS. Supplementation may reduce canker sore frequency and severity, particularly in deficient individuals.
Folate deficiency is among the most common and persistent nutritional deficiencies in celiac disease, resulting from impaired proximal intestinal absorption and possible continuation on long-term GFD. ACG 2013 guidelines recommend folate screening and supplementation at diagnosis. Multiple systematic reviews confirm folate deficiency in both newly diagnosed and treated CeD patients.
Folate is an indispensable cofactor in one-carbon metabolism, directly supporting the biosynthesis of purines, thymidylate, and S-adenosylmethionine (SAM) — processes critical for DNA replication, repair, and cellular proliferation. Folate deficiency impairs cell division in all rapidly dividing tissues. While folate does not directly fuel ATP production, it is essential for maintaining the metabolic infrastructure that enables cellular energy processes.
Vitamin B9 (folate) deficiency is a recognized risk-modifying cofactor for cervical dysplasia and HPV persistence. A 2025 meta-analysis (Frontiers in Nutrition) found higher folate levels consistently associated with reduced HPV persistence and lower cervical dysplasia risk across four studies (pooled SMD 0.80; p<0.00001). A Hawaii case-control study found total folate intake inversely dose-responsive with both low- and high-grade SIL. Supplementation trials have not confirmed regression of established CIN.
Folate (vitamin B9) is essential for DNA synthesis, cell division, and amino acid metabolism, with IOM-established RDAs for children. NIH ODS-funded label analysis found folic acid (folate form) in the 13 core nutrients at or above RDA in most children's MVMs, though overages exceeding the UL were identified in some products.
Folate (Vitamin B9) is essential for DNA synthesis and red blood cell maturation. Deficiency causes megaloblastic anemia and fatigue. EFSA authorizes a health claim for folate contributing to normal blood formation and reduction of tiredness and fatigue. It is included in the authoritative 2020 Tardy et al. review (PMC7019700) among micronutrients with recognized roles in fatigue.
Substantial epidemiological and clinical evidence links folate (vitamin B9) status to cognitive aging outcomes. Low serum folate and elevated homocysteine are consistently associated with greater cognitive decline and increased Alzheimer's disease risk. Intervention trials show benefit primarily in older adults with mild cognitive impairment and elevated homocysteine at baseline, though results in generally healthy or folate-replete populations are mixed.
Folate (vitamin B9) deficiency is well-documented in Crohn's disease. A PubMed study confirmed serum folate significantly lower in CD patients versus controls. Supplementation reduces inflammatory homocysteine, supports immune–microbiota interactions, and is especially important for patients on methotrexate or sulfasalazine.
Folate (Vitamin B9) deficiency is closely linked to depression through its role in monoamine neurotransmitter methylation and SAMe biosynthesis. Clinical trials support folate supplementation as an adjunct for depression, particularly in patients with MTHFR polymorphisms. It is included in CANMAT/WFSBP 2022 MDD adjunct guidelines.
Folate (vitamin B9) is essential for one-carbon metabolism, nucleotide synthesis, and mitochondrial function. Deficiency causes megaloblastic anemia and significant fatigue due to impaired red blood cell production and oxygen delivery. EFSA recognizes that folate contributes to normal energy-yielding metabolism and to the reduction of tiredness and fatigue.
Folate (vitamin B9) is essential for DNA synthesis and methylation during spermatogenesis. Low seminal folate correlates with increased sperm DNA fragmentation and aneuploidy. Combined zinc+folic acid improved sperm concentration in early RCTs. However, a 2020 NIH-funded RCT (n=2,370) found no improvement in live births, indicating benefits are most likely in folate-deficient men.
Folate (naturally occurring vitamin B9) supports ovulatory function and early embryo development. Higher intake correlates with reduced anovulation risk, shorter time to pregnancy, and better ART outcomes in observational and RCT evidence. The standard preconception recommendation is 400–800 mcg/day.
Folate is essential for one-carbon metabolism, neurotransmitter synthesis, and DNA methylation in developing brains. Studies document lower folate levels in children with ADHD compared to controls. A 2024 network meta-analysis of 48 pediatric ADHD studies (n=3,650) included folic acid as one of 12 evaluated nutrient interventions and found a favorable safety profile.
Observational studies consistently link higher serum folate to reduced periodontal disease risk. A systematic review found each standard deviation increase in serum folate was associated with approximately 26% lower odds of periodontal disease. Folate deficiency impairs gingival keratinization, collagen formation, and resistance to infection. Folate mouthwash and dietary folate have both been associated with reduced gingival bleeding.
Folate is a B-vitamin essential for DNA synthesis, methylation, and repair — processes critical to genomic stability and epigenetic regulation in aging. Low folate is associated with elevated homocysteine, increased cancer risk, cognitive decline, and accelerated epigenetic aging. The Oxford B-vitamin RCT confirmed combined folate and B12 supplementation significantly reduces brain atrophy in older adults.
Folate (vitamin B9) is essential for DNA synthesis, cell division, and neural tube development, making it among the most critical nutrients for fetal and early childhood growth. The CDC identifies insufficient folate as a direct cause of neural tube defects and notes its association with low birth weight, preterm delivery, and fetal growth retardation. Deficiency in children causes megaloblastic anemia, weight loss, and stunted growth.
Folate (vitamin B9) reduces homocysteine levels, which when elevated impair cochlear blood flow and contribute to sensorineural hearing loss. Multiple population studies, including NHANES data, link low folate status to higher rates of hearing loss. Women with hearing impairment had 43% lower red-cell folate than those with normal hearing in a landmark PubMed study.
Vitamin B9 (folate) has well-documented mechanistic and clinical links to cardiovascular health, primarily through lowering plasma homocysteine, improving endothelial function, and reducing stroke risk. A meta-analysis of 30 RCTs (82,334 participants) published in the Journal of the American Heart Association found a 10% lower stroke risk and 4% lower overall CVD risk with folic acid supplementation. However, benefits are most evident in folate-deficient populations or those without pre-existing CVD; in folate-replete populations, supplementation generally shows no added cardiovascular benefit. Folate also exerts homocysteine-independent effects on vascular function via nitric oxide pathways.
Folate is the naturally occurring form of vitamin B9 and the principal nutrient involved in homocysteine remethylation. As 5-methyltetrahydrofolate, it donates a methyl group to convert homocysteine to methionine. Numerous RCTs confirm folate supplementation significantly reduces plasma homocysteine; Linus Pauling Institute designates folate as a primary nutrient for homocysteine metabolism.
Folate (vitamin B9) is required for red blood cell DNA synthesis; deficiency causes megaloblastic anemia with fatigue as the predominant symptom. Supplementation corrects deficiency-related anemia and associated fatigue, particularly relevant when co-occurring with iron deficiency.
Folate (vitamin B9) is essential for one-carbon metabolism, DNA methylation, and neurotransmitter synthesis. It reduces homocysteine, a neurotoxic amino acid elevated in cognitive decline. A 2024 meta-analysis of RCTs found folate supplementation significantly improved global cognitive function in MCI patients, with an effect size (SMD=1.21) greater than combined B-vitamin formulations.
Folate (vitamin B9) is essential for one-carbon metabolism, DNA methylation, and homocysteine regulation relevant to neuronal function and memory. A large 3-year RCT found folate supplementation significantly improved memory in adults aged 50–70 with elevated homocysteine. Evidence is strongest in populations with elevated homocysteine or deficiency, where memory improvements are clinically meaningful.
Folate (vitamin B9) is essential for one-carbon metabolism, neurotransmitter biosynthesis, and DNA synthesis. Deficiency causes fatigue and cognitive impairment; adequate folate supports mental energy, and EU health claims recognize its contribution to normal psychological function.
Folate (vitamin B9) facilitates transport of methyl groups in the one-carbon pathway for DNA methylation and homocysteine remethylation. Deficiency produces global hypomethylation and impaired SAMe synthesis. It is among the most extensively studied methylation-supporting nutrients, with strong mechanistic, epidemiological, and clinical evidence.
Folate (vitamin B9), often combined with B6 and B12, has been studied for migraine prevention, particularly in patients with elevated homocysteine. RCTs combining folic acid 2 mg/day with B6 and B12 for 6 months significantly reduced migraine severity, disability, and homocysteine levels. Folic acid alone at lower doses showed less consistent benefit.
Folate is required for mitochondrial one-carbon metabolism and de novo purine synthesis, directly contributing to the nucleotide precursors (ATP, GTP) used in mitochondrial energy systems. Mitochondrial SHMT2 and MTHFD2 enzymes depend on folate, and folate deficiency impairs mtDNA synthesis and mitochondrial function.
Folate is required for DNA synthesis and cell division, both critical for the rapidly dividing nail matrix keratinocytes. Deficiency impairs nail matrix cell production, leading to brittle or abnormal nails. PMC and clinical sources identify folate deficiency as a nutritional cause of nail abnormalities. It is recognized alongside B12 as a cell-division nutrient essential for normal nail growth.
Folate (vitamin B9) is essential for nervous system development and maintenance, critical for one-carbon methylation supporting neurotransmitter synthesis and homocysteine metabolism. Deficiency causes neural tube defects and is linked to peripheral neuropathy, depression, and dementia.
Folate deficiency is a documented cause of peripheral neuropathy, presenting as slowly progressive axonal sensory neuropathy predominantly in the lower extremities. Folate supports nerve health via myelin maintenance, reduction of neurotoxic homocysteine, and neuronal DNA repair. A 2025 systematic review found folate supplementation consistently improved neuropathy biomarkers and nerve conduction parameters in clinical trials, though definitive efficacy data remain limited.
Folate is essential for generating SAMe, the methyl donor for neurotransmitter synthesis. Folate deficiency is among the most replicated nutritional associations with depression. MTHFR gene variants link folate metabolism to neurotransmitter imbalance. Meta-analyses confirm lower serum folate in depression; adjunctive folate improves antidepressant outcomes.
Folate (vitamin B9) is among the specific vitamins listed in major PCOS supplement systematic reviews as having evidence of benefit. It reduces elevated homocysteine—a recognized cardiovascular risk factor in PCOS—and may reduce BMI in PCOS women with high homocysteine levels.
Folate (vitamin B9) is documented as a key micronutrient deficient in picky eating children. An RCT of oral nutritional supplementation in picky eaters showed significant reduction in folate inadequacy. Folate is critical for DNA synthesis, cell division, and normal growth in children.
Folate is essential for immune cell DNA synthesis and red blood cell production during post-illness recovery. Deficiency impairs lymphocyte reconstitution and contributes to post-illness anemia and fatigue. Standard post-operative and post-illness nutritional protocols include folate as a core component.
Folate (Vitamin B9) is essential for one-carbon metabolism supporting DNA synthesis, methylation reactions, and homocysteine clearance—all impaired in post-viral states. EFSA recognizes folate for reducing tiredness and fatigue, normal immune function, and normal psychological function. B9 deficiency is common in long COVID patients alongside other B vitamin deficiencies.
Folate is required for red blood cell synthesis, DNA repair, and tissue healing postpartum. It is actively secreted into breastmilk, increasing maternal demand. Multiple clinical authorities including WHO and NIH ODS recommend it as a critical postnatal nutrient. Postpartum women typically consume far less folate than recommended from food alone.
Folate (natural food-form vitamin B9) is essential for fetal neural tube closure, DNA synthesis, and cell division during pregnancy. The NIH ODS specifically lists folate/folic acid among nutrients with critical prenatal roles that are underconsumed. Adequate periconceptional folate reduces NTD risk by over 70% and supports prevention of megaloblastic anemia. The RDA increases to 600 mcg DFE/day during pregnancy.
Low serum folate is associated with RLS risk specifically in pregnant women, and folic acid administration has been shown to alleviate RLS symptoms, potentially playing a role in primary familial RLS treatment. Pregnant women with lower folate levels were significantly more likely to develop RLS than those supplementing with vitamins during pregnancy.
Folate is co-administered with methotrexate in RA to reduce MTX-induced side effects including mucositis and hepatotoxicity, without compromising anti-arthritic efficacy, as supported by Cochrane reviews and ACR/EULAR RA treatment guidelines. EBSCO Research Starters lists folate as a proposed natural treatment for RA.
Folic acid (vitamin B9) supports DNA methylation and synthesis and has been proposed to contribute to melanin biosynthesis. Consistently studied alongside vitamin B12 in vitiligo, with several uncontrolled studies reporting improved repigmentation. Evidence from controlled trials is mixed and overall inconclusive per authoritative systematic reviews.
Folate (vitamin B9) is essential for DNA synthesis in rapidly dividing hair matrix cells. Deficiency has been linked to androgenetic alopecia progression in systematic reviews. Routine supplementation without documented deficiency is not currently supported by clinical guidelines.
Volver